|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/48 | |
| C07K 14/33 | |||
| C12N 9/52 | |||
| A61P 35/00 | |||
| C07K 14/495 | |||
| C07K 14/50 | |||
| C07K 14/52 | |||
| C07K 14/54 | |||
| C07K 14/65 | |||
| C07K 14/705 | |||
| C07K 14/485 | |||
| C07K 14/475 | |||
| C12N 9/50 | |||
| A61K 47/50 |
| (11) | Patento numeris | 2664343 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13167699.1 |
| Europos patento paraiškos padavimo data | 2009-11-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-11-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-03-29 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 0820970 | 2008-11-17 | GB |
| (72) |
Madec, Frederic, GB
Lecane, Philip, GB
Marks, Philip, GB
Foster, Keith, GB
|
| (73) |
Ipsen Bioinnovation Limited,
102 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY,
GB
|
| (54) | Suppression of cancer |
| Suppression of cancer |